School of Medicine
Showing 1-10 of 244 Results
-
Jennifer Anne Rabbitts
Professor of Anesthesiology, Perioperative & Pain Medicine (Pediatric) and, by courtesy, of Pediatrics
BioJennifer Rabbitts, MD is Professor and Chief of Pediatric Pain Management at Stanford University School of Medicine. Dr. Rabbitts directs an NIH-funded research laboratory focused on improving long-term pain and health outcomes in children and adolescents undergoing surgery. Her research is devoted to understanding and preventing chronic postsurgical pain, a disabling condition affecting 20% youth undergoing major surgery. Her current research studies investigate the role of biopsychosocial mechanisms including child psychosocial factors, parental/family factors, and psychophysical processes underlying acute to chronic pain transition. Current clinical trials focus on testing feasibility and efficacy of psychosocial and complementary and integrative interventions to improve acute postsurgical pain and prevent transition to chronic pain.
Dr Rabbitts is passionate about mentoring, and is a PI for the NIH HEAL PAIN Training grant in Maternal and Child Pain and Health at Stanford. She serves as mentor for the Women's Empowerment and Leadership Initiative and for the Mission Driven Mentoring Program for Diversity, Equity, and Inclusion, of the Society for Pediatric Anesthesia. She is a section editor for Psychology, Psychiatry and Brain Neuroscience Section for Pain Medicine, and serves on the editorial boards for Pediatric Anesthesia and Journal of Pain.
Read more about the Rabbitts Lab and opportunities here: https://rabbittslab.stanford.edu/ -
Marlene Rabinovitch
Dwight and Vera Dunlevie Professor of Pediatric Cardiology
Current Research and Scholarly InterestsOur research program seeks to identify the cellular and molecular programs regulating vascular and lung development, through the use of cultured cells and tissues and mouse and rat models. We then determine how these programs are perturbed by genetic abnormalities or injurious processes associated with disease, focusing on pulmonary arterial hypertension (PAH), a fatal complication in children with heart defects, and a condition of unknown etiology primarily in young women.
-
Ralph Rabkin
Professor of Medicine, Emeritus
Current Research and Scholarly InterestsDr Rabkin is examining the mechanism of the acquired resistance to hormones that develops in kidney failure.In particular he is studying the impact of kidney failure on the action of growth hormone and the role of impaired signal transduction as a cause of growth hormone resistance. He is also engaged in the study of growth factors in diabetic kidney disease.
-
Helge Raeder MD PhD
Visiting Professor, Genetics
BioHelge Ræder is a Full Professor at the Faculty of Medicine, University of Bergen (UiB), Norway and a Senior Consultant in Pediatric Endocrinology at Haukeland University Hospital, Bergen, Norway. With a background in cellular biology and diabetes research, he has significantly contributed to understanding diabetes through stem cell research. He has been a visiting scholar at Joslin Diabetes Center, Harvard Medical School with C. Ronald Kahn (2005-2006) and with Rohit N Kulkarni (2010-2011). As the Vice Dean of Innovation at UiB (2017-2024), he has spearheaded the establishment of ecosystems that catalyze breakthrough innovations, including a new Medical Innovation Centre. His research aims to unravel the biology of diabetes and endocrine disorders, focusing on the interplay between genetics, proteomics, and stem cell biology. Dr. Ræder's work has resulted in publications in high-impact journals including Nature, Nature Genetics, Nature Metabolism, Diabetes, Journal of Bone and Mineral Research and Nature Reviews Endocrinology. He has been recognized with several awards, including the Young Investigator’s Award from the International Society for Pediatric and Adolescent Diabetes. He has been an invited speaker at the IPITA-JDRF-HSCI Key opinion leader´s meeting on stem cell-derived beta cells at Harvard Medical School. Currently, he is a visiting professor at Stanford University, contributing to precision health research focusing on developing endocrine digital twins at Prof. Michael Snyder's Lab.
-
Thomas Raffin
The Colleen and Robert Haas Professor in Medicine and Biomedical Ethics, Emeritus
Current Research and Scholarly InterestsDr. Raffin is a clinician, teacher and investigator. He retired as Chief of the Division of Pulmonary and Critical Care Medicine in 2004. His key areas of academic interest include the biology and management of acute lung injury; basic biology of human lung and white cells; and, key issues in biomedical ethics including withholding and withdrawing life support, health care delivery, genomics, genetic screening, and neuroethics.
-
Nilima Ragavan
Clinical Professor, Pediatrics - Neonatal and Developmental Medicine
BioDr Nilima Ragavan is an experienced clinician who has expertise in the care of newborns ranging from critically ill to well babies. She is passionate about education and is the director of the Stanford pediatric resident rotation in the neonatal intensive care unit. She has led several multi disciplinary teams to India, and has organized and conducted international neonatal and perinatal conferences. She is a member of the palliative care team and serves as a mentor to junior faculty. She is the medical director of the Packard Special Care nursery at Sequoia, and also attends in the NICU at Stanford.
-
Amer Raheemullah
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Amer Raheemullah, MD, is Associate Clinical Professor of Psychiatry and Behavioral Sciences. He specializes in the treatment of addictive behavior, has published chapters and peer-reviewed articles in this area, and is Director of the Addiction Inpatient Medicine Service at Stanford Hospital. He is board-certified in Addiction Medicine and Internal Medicine.
-
Ehsan Rahimy
Adjunct Clinical Assistant Professor, Ophthalmology
BioDr. Ehsan Rahimy specializes in the medical and surgical management of diseases affecting the retina, with a clinical expertise in macular degeneration, diabetic retinopathy, retinal detachment, macular hole, macular pucker/epiretinal membranes, and uveitis.
Dr. Rahimy has authored well over 100 peer-reviewed publications, numerous book chapters, as well as other non-peer reviewed literature. He presents regularly at national and international ophthalmic meetings, having contributed over 200 conference abstracts.
He is passionate about the interplay between technology and medicine, and how ongoing advancements will transform healthcare delivery in the near future. Dr. Rahimy is frequently consulted for collaborative research endeavors and advises on numerous early stage companies involved in ophthalmology, telemedicine, A.I., and other medtech innovation.
Dr. Rahimy graduated with highest distinction from the University of Michigan, followed by receiving his medical degree, with high honors, at Baylor College of Medicine. During this time, he was one of a select few junior inductees into the Alpha Omega Alpha (AOA) Honor Society. He went on to complete his ophthalmology residency at the world-renowned Jules Stein Eye Institute at UCLA, recognized as one of the premier residency programs in the country, where he received the Pepose-Saltzman Young Investigator Research Award, Henry & Lilian Nesburn Research Award, and the Devgan Outstanding Surgical Resident Award. Afterwards, he pursued subspecialty training in vitreoretinal surgery at Wills Eye Hospital, considered the preeminent retinal fellowship program in the country, under the guidance and mentorship of many of the field's leaders. While there, he was awarded a Heed Fellowship, the Ronald G. Michels Fellowship Award, and the William B. Tasman Outstanding Fellow Award. -
Elham Rahimy, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Rahimy is a radiation oncologist who treats patients with brain, spine, and gastrointestinal tumors. She received her medical training at Yale, followed by a residency in radiation oncology at Stanford. She is a clinical assistant professor with the Stanford School of Medicine Department of Radiation Oncology.
Dr. Rahimy specializes in treating several types of cancer, including brain tumors, such as glioma and glioblastoma, spine tumors, metastatic disease, and gastrointestinal cancer, such as rectal cancer and pancreatic cancer. She is credentialed for CyberKnife Radiosurgery. She is also actively involved in radiation oncology research and clinical trials. Her interests include improving patient and resident education and enhancing patient quality of life and survivorship. Dr. Rahimy’s research has been published in a variety of journals. She is also the current radiation oncology medical student clerkship director.
